都福美股招股说明书(2025-11-05版)

Table of Contents Filed Pursuant to Rule 424(b)(2)Registration No. 333-269991 The information in this preliminary prospectus supplement and the accompanyingprospectus is not complete and may be changed. This preliminary prospectussupplement and the accompanying prospectus are not an offer to sell thesesecurities and are not soliciting an offer to buy these securities in any jurisdictionwhere the offer or sale is not permitted. Subject to Completion, dated November 5, 2025 PRELIMINARY PROSPECTUS SUPPLEMENT(to Prospectus dated February 24, 2023) Dover Corporation % Notes due 20 Dover Corporation is offering €aggregate principal amount of%notes due 20(the “notes”). The notes will bear interest at the rate of% per year, which interest shall accrue from, 2025. Interest on thenotes will be payable in arrears annually on, commencing,2026. The notes will mature on, 20. We may redeem some or all of the notes at any time, at the “make-whole”redemption price indicated under the heading “Description of Notes—Optional Redemption” beginning on page S-15 of this prospectus supplement.In addition, the notes may be redeemed in whole but not in part, at any time atour option, in the event of certain developments affecting U.S. taxation. See“Description of Notes—Redemption for Tax Reasons” on page S-17 of thisprospectus supplement. Upon the occurrence of a change of control triggering event, the holders ofthe notes may require us to repurchase some or all of their notes at apurchase price equal to 101% of the principal amount of the notes plusaccrued interest to, but excluding, the repurchase date. See “Description ofNotes—Change of Control” beginning on page S-18 of this prospectussupplement. The notes will be our senior unsecured debt obligations and will rank onparity with all of our other senior unsecured indebtedness. The notes willnot be convertible or exchangeable for any other securities. The notes willbe issued in denominations of €100,000 and integral multiples of €1,000 inexcess thereof. Investing in our notes involves risks that are describedunder “Risk Factors” beginning on page S-5 of this prospectussupplement and under “Risk Factors” on page 1 of theaccompanying prospectus. Neither the Securities and Exchange Commission (the “SEC”) nor any otherregulatory body has approved or disapproved of these securities ordetermined if this prospectus supplement or the accompanying prospectusis truthful or complete. Any representation to the contrary is a criminaloffense. (1)Plus accrued interest, if any, from, 2025. We intend to apply to list the notes on The New York Stock Exchange (the“NYSE”). The listing application will be subject to the approval by the NYSE.We expect listing of the notes on the NYSE to occur within 30 days after theoriginal issue date. If such listing is obtained, we have no obligation tomaintain such listing, and we may delist the notes at any time. We expect to deliver the notes to purchasers through the book-entrydelivery system of Euroclear Bank SA/NV (“Euroclear”) and ClearstreamBanking S.A. (“Clearstream”) on or about, 2025, which is theLondon business day following the date of this prospectus supplement.Purchasers of the notes should note that trading of the notes may beaffected by this settlement date. Joint Book-Running Managers ING HSBCJ.P. Morgan Table of Contents TABLE OF CONTENTSProspectus SupplementPageAbout This Prospectus SupplementS-iiIncorporation by ReferenceS-vForward-Looking StatementsS-viSummaryS-1Risk FactorsS-5Use of ProceedsS-10CapitalizationS-11Description of NotesS-12Certain United States Federal Income Tax ConsiderationsS-25Certain ERISA ConsiderationsS-32UnderwritingS-35Legal MattersS-41ExpertsS-41 Prospectus About This ProspectusDover CorporationRisk FactorsWhere You Can Find More InformationIncorporation by Reference Forward-Looking StatementsUse of ProceedsDescription of Debt SecuritiesPlan of DistributionLegal MattersExperts Table of Contents ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is this prospectus supplement, whichdescribes the specific terms of the offering of the notes and other matters relatingto us and our business, properties, financial condition, results of operations andprospects. The second part is the accompanying prospectus, which gives more generalinformation about debt securities we may offer from time to time, some of which doesnot apply to the notes we are offering. Generally, when we refer to the prospectus, weare referring to both parts of this document combined. To the extent that informationin this prospectus supplement or the information incorporated by reference in thisprospectus supplement is inconsistent with information in the accompanyingprospectus, the information in this prospectus supplement or the informationincorporated by reference in this prospectus supplement replaces the information inthe accompanying prospectus. Except as the context otherwise requires, or as otherwis